Table 1.
AMXa | CIP | CLR | FUR | MTZ | TET | Total | |
---|---|---|---|---|---|---|---|
No. isolates | 47 (23.9%) | 68 (34.5%) | 89 (45.2%) | 121 (61.4%) | 129 (65.5%) | 73 (37.1%) | 197 |
Age Range | 20–71 | 18–71 | 18–74 | 18–71 | 18–74 | 18–68 | 18–74 |
Mean Age | 40.9 | 39.4 | 39.6 | 40 | 38.9 | 37.7 | 40.7 |
Males | 23 | 39 | 51 | 64 | 67 | 42 | 102 |
Age Range | 20–68 | 18–71 | 18–74 | 18–71 | 18–74 | 18–68 | 18–74 |
Mean Age | 39.2 | 40.9 | 40.7 | 39.6 | 38.6 | 37.9 | 40.4 |
Females | 24 | 29 | 38 | 57 | 62 | 31 | 95 |
Age Range | 21–71 | 19–67 | 18–71 | 18–71 | 18–67 | 18–64 | 18–71 |
Mean Age | 42.5 | 37.4 | 38.2 | 40.5 | 39.3 | 37.3 | 41 |
AMX - amoxicillin, CIP - ciprofloxacin, CLR - clarithromycin, FUR - furizoladone, MTZ - metronidazole, and TET - tetracycline
The number of isolates is indicated and the corresponding percentage of the total each represents is given in parentheses.